BioAlliance Pharma SA, the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, announced the initiation of its European marketing application for ondansetron RapidFilm, the fast-dissolving oral film strip formulation of ondansetron (which until now has been used in tablet form).
The details can be read here.
No comments:
Post a Comment